HIV-1感染者早期启动高效抗逆转录病毒治疗的获益与风险
被引量:1
摘要
自1996年高效抗逆转录病毒治疗(HAART)进入临床实践以来,HIV-1感染患者AIDS的发病率和病死率均显著下降,HAART成为针对HIV-1感染患者的基本治疗方案。然而,对于启动HAART的时机问题,长期以来存在不同的认识。目前各个权威性指南一致认为在CD4T淋巴细胞计数〈350/μl时,无论有无症状,都应启动HAART。
出处
《中华内科杂志》
CAS
CSCD
北大核心
2010年第8期710-713,共4页
Chinese Journal of Internal Medicine
参考文献36
-
1Palella FJ Jr,Delaney KM,Moorman AC,et al.Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.HIV Outpatient study Investigator.N Engl J Med,1998,338:853-860.
-
2Palella FJ Jr,Baker RK,Moorman AC,et al.Mortality in the highly active antiretroviral therapy era:changing causes of death and disease in the HIV outpatient study.J Acquir Immune Defic Syndr,2006,43:27-34.
-
3Toro PL,Katyal M,Carter RJ,et al.Initiation of antiretroviral therapy among pregnant women in resource-limited countries:CD4 + cell count response and program retention.AIDS,2010,24:515-524.
-
4Department of Health and Human Services.Guidelines for the use of antiretroviral agents in HIV-1 -infected adults and adolescents.2009.[2010-05-16].http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
-
5European AIDS Clinical Society.Clinical management and treatment of HIV infected adults in Europe.2009.5th ed.[2010-05-18].http://hivpolicy.ru/publications/index.php? id =765&file = 1518.
-
6World Health Organization.Rapid advice:antiretroviral therapy for HIV infection in adults and adolescents.2009.[2010-05-17].http://www.who.int/hiv/pub/arv/rapid_advice_art.pdf.
-
7王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:632
-
8卫生部艾滋病临床专家工作组.国家免费艾滋病抗病毒药物治疗手册.[2010-05-18].http://www.chinaids.org.cn/n16/n1657/n32880.files/n32881.pdf.
-
9Sax PE,Baden LR.When to start antiretroviral therapy-ready when you are? N Engl J Med,2009,360:1897-1899.
-
10Bangsberg DR,Acosta EP,Gupta R,et al.Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.AIDS,2006,20:223-231.
共引文献631
-
1朱翠萍.AIDS合并巨细胞病毒性视网膜炎79例的诊治[J].中国实用眼科杂志,2018,36(1):24-27. 被引量:2
-
2邱红艳.艾滋病合并肺孢子菌肺炎的临床特点及预后分析[J].医学信息,2023,36(S01):83-85.
-
3华欣,魏国,赵勇,何永,蔡林,刘林,何敏.淋巴结活检术在HIV/AIDS合并颈部淋巴结核诊断中的应用[J].医学信息(医学与计算机应用),2014,0(31):33-34. 被引量:1
-
4夏群,夏跃雄,崔建国.宫颈癌伴HIV阳性患者的放射治疗方法及临床疗效观察[J].云南医药,2013,34(4):303-305. 被引量:1
-
5肖江,郜桂菊,李鑫,韩宁,王凌航,刘龙,杨涤,张黎颖,赵红心,毛羽.艾滋病并发脂肪肝患者HAART治疗后左心室结构及功能变化[J].中国肝脏病杂志(电子版),2010,2(4):7-11. 被引量:1
-
6黄雪梅.10例艾滋病患者的护理体会[J].求医问药(下半月),2013(9):231-232. 被引量:1
-
7邓英丽,韦文冰.循证护理对艾滋病患者自我管理疾病能力的影响[J].中国临床护理,2014,6(5):418-420. 被引量:5
-
8李太生.对获得性免疫缺陷综合征主要机会性感染的认识[J].内科理论与实践,2006,1(1):20-22. 被引量:12
-
9赵红心.艾滋病的农村防治问题和策略[J].中华全科医师杂志,2006,5(11):662-663. 被引量:1
-
10吉英杰,赵敏,孙艳玲,姜天俊,赵景民,秦恩强,张昕.丙型肝炎病毒和人类免疫缺陷病毒合并感染者肝组织病理学观察[J].中华内科杂志,2006,45(11):939-941. 被引量:2
同被引文献36
-
1王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:632
-
2卫生部艾滋病临床专家工作组.国家免费艾滋病抗病毒药物治疗手册.[2010-05-18].http://www.chinaids.org.cn/n16/n1657/n32880.files/n32881.pdf.
-
3Jonsson Funk M,Fusco JS,Cole SR,et at.HAART initiation and clinical outcomes:insights from the CASCADE cohort of HIV-1seroconverters on " When to Start".X Ⅷ International AIDS Conference,Vienna,2010.[2010-09-19].http://pag.aids2010,org/Abstraets,aspx? AID = 16875.
-
4National Institute of Allergy and Infectious Diseases (NIAID),Copenhagen HIV Programme (CHIP),Medical Research Council (MRC) Clinical Trials Unit.Strategic Timing of AntiretroviralTreatment (START).[2010-09-24].http://clinicaltrials,guy/ct2/show/NCT00867048.
-
5Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),National Institute on Drug Abuse (NIDA),National Institute of Mental Health (NIMH).Preventing Sexual Transmission of HIV With Anti-HIV Drugs.[2010-09-24].http://clinicaltrials.gov/ct2/show/NCT00074581.
-
6Volberding PA,Lagakos SW,Koch MA,et al.Zidovudine in asymptomatic human immunodeficiency virus infection.A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter.The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.N Engl J Med,1990,322:941-949.
-
7Volberding PA,Lagakos SW,Grimes JM,et al.A comparison of immediate with deferred zidovudine therapy for asymptomatic HIVinfected adults with CD4 cell counts of 500 or more per cubic millimeter.AIDS Clinical Trials Group.N Engl J Med,1995,333:401-407.
-
8Carpenter CC,Fisehl MA,Hammer SM,et al.Antiretroviral therapy for HIV infection in 1997.Updated recommendations of the International AIDS Society-USA panel.JAMA,1997,277:1962-1969.
-
9Yeni PG,Hammer SM,Carpenter CC,et al.Antiretroviral treatment for adult HIV infection in 2002:updated recommendations of the International AIDS Society-USA Panel.JAMA,2002,288:222-235.
-
10Lampe FC,Gatell JM,Staszewski S,et al.Changes over time in risk of initial virological failure of combination antiretroviral therapy:a muhicohort analysis,1996 to 2002.Arch Intern Med,2006,166:521-528.
二级引证文献3
-
1李太生,弓孟春,范思远.2011年HIV/AIDS临床研究进展[J].医学研究杂志,2012,41(6):2-4. 被引量:1
-
2金艳涛,郭会军,蒋自强.无症状期人类免疫缺陷病毒感染者外周血CD_4^+T淋巴细胞计数与总淋巴细胞计数的相关性分析[J].中国全科医学,2013,16(26):3081-3083. 被引量:5
-
3左孝红,蒋毓文,陈建,王琴芳,张志.109例次HIV/AIDS住院患者临床与实验室检查特征[J].皖南医学院学报,2014,33(2):137-139. 被引量:2
-
1周福成.替罗非斑在急性心肌梗死中的获益与风险[J].中国医药指南,2013,11(3):165-166.
-
2Ruiz - Nodar JM.药物洗脱支架用于房颤患者中的有效性与安全性评价[J].国际老年医学杂志,2010,31(5):238-238.
-
3贾衍尧,胡桃红,丁力平.吸烟对氯吡格雷疗效及安全性的影响[J].中国心血管病研究,2016,14(9):773-775.
-
4王健,梁碧颜,陆嘉明,张小平,徐立然,邓鑫,李秀惠,方路,谭行华,毛宇湘,张国梁.中药治疗连续60个月的565例HIV/AIDS病人的CD_4T淋巴细胞消长特征[J].中国艾滋病性病,2013,19(7):468-471. 被引量:19
-
5马玉真.冠心病患者抗血小板治疗致上消化道事件分析与对策[J].中国实用医药,2012,7(25):91-92. 被引量:5
-
6张力,张晓艳,刘平,苏日格,刘丽芳,魏璇.高龄老年高血压患者的降压治疗策略[J].医学与哲学(B),2009,30(9):25-27. 被引量:1
-
7邓体瑛,张恩景.慢性阻塞性肺疾病合并支气管扩张患者长期使用ICS的获益与风险[J].中国现代药物应用,2016,10(19):232-233.
-
8徐娜,袁晋青.高龄非血运重建急性冠状动脉综合征患者的抗血小板治疗进展[J].心血管病学进展,2016,37(2):108-111. 被引量:2
-
9陈晓云,潘道蓉,庞思,余洁.急性心肌梗死患者入绿色通道后获益与风险评估[J].海南医学,2015,26(14):2062-2065. 被引量:9
-
10海静如.急性冠脉综合征并阵发性心房颤动介入治疗术后短程抗栓治疗回顾性研究[J].广西医科大学学报,2012,29(3):403-405. 被引量:6